295 results
Long‐term safety of paclitaxel drug‐coated balloon‐only angioplasty for de novo coronary artery disease: the SPARTAN DCB study
16 Sep 2020
This study adds to the growing body of evidence demonstrating that DCB is a safe option for the treatment of de novo coronary lesions with NO signal towards increase in mortality up to 5-year follow-up.
Reviewer
Reviewer
Timing of oral P2Y12 inhibitor administration in non-ST elevation acute coronary syndrome
08 Sep 2020
What do you do in your daily practice: Do you use routine pre-treatment in NSTEMI patients? Have you modified your practice based on the new ESC guidelines?
Reviewer
Transcarotid vs subclavian/axillary access for transcatheter aortic valve replacement with SAPIEN 3
20 Aug 2020
The purpose of this study is to report outcomes of TC and TAx access using the Edwards SAPIEN 3 and SAPIEN 3 Ultra valves from the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapies (TVT) Registry.
Reviewer
MIRTOS trial: Ticagrelor versus Clopidogrel in patients with STEMI treated with thrombolysis
07 Aug 2020
The MIRTOS trial, which included STEMI patients receiving DAPT and thrombolysis ‘together’, aimed to evaluate whether ticagrelor could improve microvascular perfusion and reduce MACE compared to clopidogrel
Reviewer
Reviewer
Safety of Revascularization Deferral of Left Main Stenosis Based on Instantaneous Wave-Free Ratio Evaluation
05 Aug 2020
The main message appears to be that iFR-based deferral of LM revascularization is not linked to an excessive risk of MACE during 30-month median follow-up. Given the historical predominance of angiography-based decision making, this study provides further evidence in support of thinking and acting beyond angiography...
Reviewer
Cangrelor, Tirofiban and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial
15 Jul 2020
The results of the FABOLUS FASTER trial clearly highlight that a high residual platelet reactivity persists when targeting platelet activation by inhibition of the P2Y12 receptor either with Prasugrel or Cangrelor, while tackling the mechanism of platelet adhesion thought the inhibition of GPIIB/IIIA might almost completely...
Reviewer
Multivessel versus culprit-only revascularisation in STEMI and multivessel coronary artery disease: meta-analysis of randomised trials
23 Jul 2020
The current meta-analysis study sought to evaluate contemporary randomized trials on multivessel versus IRA-only PCI in patients presenting with STEMI and multivessel CAD.
Reviewer
Multicentre, randomised comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial
22 Jul 2020
DEFINITION-II adds to the evidence that an upfront 2-stent strategy may be most appropriate in true complex bifurcation lesions.
Reviewer
Intravascular healing is not affected by approaches in contemporary CTO PCI: the CONSISTENT CTO study
16 Jul 2020
This study compares clinical, angiographic and imaging outcomes of patients undergoing CTO PCI with dissection and re-entry techniques (DART) and subintimal stenting to intimal techniques.
Reviewer
Subcutaneous selatogrel inhibits platelet aggregation in patients with acute myocardial infarction
07 Jul 2020
This study sought to assess the antiplatelet response to selatogrel, a novel subcutaneous reversible P2Y12 receptor antagonist, in patients with AMI.
Reviewer
Reviewer
